Physician profile
Donna M Eversley
NPI 1548245087
$5,849.08
in general payments reported to CMS, 2019-2025
44 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $420 · 2021: $148 · 2022: $227 · 2023: $1,191 · 2024: $1,638 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,073.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $715.59 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $667.93 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $660.52 | 2021-2025 | |
| Pfizer INC. | $565.24 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $294.44 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Astellas Pharma US INC | $219.21 | 2023-2025 | Veozah |
| Glaxosmithkline, LLC. | $207.60 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $197.17 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $194.14 | 2019-2025 | Xifaxan |
| Exact Sciences Corporation | $149.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $146.87 | 2023-2025 | Auvelity |
| Lundbeck LLC | $134.07 | 2019-2025 | Vyepti, Rexulti |
| Abbott Laboratories | $133.06 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Biohaven Pharmaceuticals, INC. | $131.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $129.95 | 2019-2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Eversley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.